DATROWAY 100 mg/5mL
Datopotamab Deruxtecan · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Daiichi Sankyo Inc.
Datroway (datopotamab deruxtecan) is an intravenous injection used to treat certain types of cancer. It belongs to a class of drugs called antibody-drug conjugates, which work by delivering cancer-fighting medication directly to tumor cells.
Key Facts
- Brand Name
- DATROWAY
- Generic Name
- Datopotamab Deruxtecan
- NDC Code (Product)
65597-801- Manufacturer
- Daiichi Sankyo Inc.
- Strength
- 100 mg/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761394
- Marketing Start
- 01/17/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is DATROWAY used for?
Datroway (datopotamab deruxtecan) is an intravenous injection used to treat certain types of cancer. It belongs to a class of drugs called antibody-drug conjugates, which work by delivering cancer-fighting medication directly to tumor cells.
Is DATROWAY a controlled substance?
DATROWAY is not classified as a controlled substance by the DEA.
What is the generic name for DATROWAY?
The generic name for DATROWAY is Datopotamab Deruxtecan. There are no other listed brand versions of Datopotamab Deruxtecan.
What is the NDC code for DATROWAY 100 mg/5mL?
The NDC (National Drug Code) for DATROWAY 100 mg/5mL is 65597-801, listed by Daiichi Sankyo Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)